BURLINGTON, N.J. (PRWEB) March 29, 2018
Fuji Chemical Industries USA, Inc., a subsidiary of Fuji Chemical Industries Japan, has announced the promotion of Yasuko Kuroda to President from her former role as Vice President, effective April 1, 2018. Kuroda takes the position vacated by Charles DePrince, who has been positioned as Chairman of the company.
Kuroda joined Fuji Japan in 1997. In that same year, she transferred to the US to establish its US headquarters. Fuji Chemical specializes in high-performance excipients such as Fujicalin®, Neusilin® and F-MELT®, as well as innovative spray drying solutions (open and closed) to industries in North and South America.
Kuroda is responsible for leading continued market penetration and growth of the company and its brands. She recently was assigned to oversee sales and marketing of Fuji Chemical’s products and services in Europe.
Kuroda said she is “honored and excited to accept the new role. I have been marketing Fuji’s excipients for 20 years. It is so wonderful to see the business grow every year. I see tremendous potential for our business and I look forward to leading the company with Mr. DePrince’s guidance.”
DePrince commented, “The choice for the new President of Fuji USA could not be better than that of Yasuko Kuroda. She has the depth of knowledge and experience needed for our excipients. As Chairman, I give her my fullest support.”
About Fuji Chemical Industries, Co. Ltd.
Fuji Chemical Industries Co., Ltd. is engaged in the production and sale of pharmaceutical products/synthesis and bulk pharmaceutical products. It offers contract manufacturing services that include API manufacturing; functional APIs, such as drug intermediates; and drug products manufacturing. The company also provides excipients and drug delivery systems. AstaReal, the leading astaxanthin producer is a part of Fuji Holding company.